Cell Biology of Canonical Wnt Signaling

Literature Cited

1. Acebron SP, Karaulanov E, Berger BS, Huang Y-L, Niehrs C. 2014. Mitotic Wnt signaling promotes protein stabilization and regulates cell size. Mol. Cell 54:663–74
   [Google Scholar]
2. Albrecht LV, Bui MH, De Robertis EM 2019. Canonical Wnt is inhibited by targeting one-carbon metabolism through methotrexate or methionine deprivation. PNAS 116:2987–95
   [Google Scholar]
3. Albrecht LV, Ploper D, Tejeda-Muñoz N, De Robertis EM 2018. Arginine methylation is required for canonical Wnt signaling and endolysosomal trafficking. PNAS 115:E5317–25
   [Google Scholar]
4. Albrecht LV, Tejeda-Muñoz N, Bui MH, Cicchetto AC, Di Biagio D et al. 2020a. GSK3 inhibits macropinocytosis and lysosomal activity through the Wnt destruction complex machinery. Cell Rep 32:107973
   [Google Scholar]
5. Albrecht LV, Tejeda-Muñoz N, De Robertis EM. 2020b. Protocol for probing regulated lysosomal activity and function in living cells. STAR Protoc 1:100132
   [Google Scholar]
6. Alexander J, Bey E, Whitcutt JM, Gear JH. 1976. Adaptation of cells derived from human malignant tumours to growth in vitro. S. Afr. J. Med. Sci. 41:89–98
   [Google Scholar]
7. Appelqvist H, Wäster P, Kågedal K, Öllinger K. 2013. The lysosome: from waste bag to potential therapeutic target. J. Mol. Cell Biol. 5:214–26
   [Google Scholar]
8. Araki N, Johnson MT, Swanson JA. 1996. A role for phosphoinositide 3-kinase in the completion of macropinocytosis and phagocytosis by macrophages. J. Cell Biol. 135:1249–60
   [Google Scholar]
9. Arias E, Cuervo AM. 2020. Pros and cons of chaperone-mediated autophagy in cancer biology. Trends Endocrinol. Metab. 31:53–66
   [Google Scholar]
10. Bar-Sagi D, Feramisco JR. 1986. Induction of membrane ruffling and fluid-phase pinocytosis in quiescent fibroblasts by ras proteins. Science 233:1061–68
    [Google Scholar]
11. Behrens J, von Kries JP, Kühl M, Bruhn L, Wedlich D et al. 1996. Functional interaction of β-catenin with the transcription factor LEF-1. Nature 382:638–42
    [Google Scholar]
12. Bhanot P, Brink M, Samos CH, Hsieh J-C, Wang Y et al. 1996. A new member of the frizzled family from Drosophila functions as a Wingless receptor. Nature 382:225–30
    [Google Scholar]
13. Bilić J, Huang Y-L, Davidson G, Zimmermann T, Cruciat C-M et al. 2007. Wnt induces LRP6 signalosomes and promotes dishevelled-dependent LRP6 phosphorylation. Science 316:1619–22
    [Google Scholar]
14. Blitzer JT, Nusse R. 2006. A critical role for endocytosis in Wnt signaling. BMC Cell Biol 7:28
    [Google Scholar]
15. Bullman S, Pedamalu C, Sicinska E, Clancy TE, Zhang X. 2017. Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer. Science 358:1443–48
    [Google Scholar]
16. Cancer Genome Atlas Netw 2012. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487:330–37
    [Google Scholar]
17. Carmon KS, Gong X, Lin Q, Thomas A, Liu Q 2011. R-spondins function as ligands of the orphan receptors LGR4 and LGR5 to regulate Wnt/β-catenin signaling. PNAS 108:11452–57
    [Google Scholar]
18. Chen P-H, Chen X, Lin Z, Fang D, He X 2013. The structural basis of R-spondin recognition by LGR₅ and RNF₄₃. Genes Dev 27:1345–50
    [Google Scholar]
19. Cheng CK, Li L, Cheng SH, Ng K, Chan NP et al. 2011. Secreted-frizzled related protein 1 is a transcriptional repression target of the t(8;21) fusion protein in acute myeloid leukemia. Blood 118:6638–48
    [Google Scholar]
20. Colozza G, Jami-Alahmadi Y, Dsouza A, Tejeda-Muñoz N, Albrecht LV et al. 2020. Wnt-inducible Lrp6-APEX2 interacting proteins identify ESCRT machinery and Trk-fused gene as components of the Wnt signaling pathway. Sci. Rep. 10:21555
    [Google Scholar]
21. Colozza G, Koo BK. 2021. Wnt/β-catenin signaling: structure, assembly and endocytosis of the signalosome. Dev. Growth Differ. https://doi.org/10.1111/dgd.12718
    [Crossref] [Google Scholar]
22. Commisso C, Davidson SM, Soydaner-Azeloglu RG, Parker SJ, Kamphorst JJ et al. 2013. Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells. Nature 497:633–37
    [Google Scholar]
23. Condon ND, Heddleston JM, Chew T-L, Luo L, McPherson PS et al. 2018. Macropinosome formation by tent pole ruffling in macrophages. J. Cell Biol. 217:3873–85
    [Google Scholar]
24. Cosman F, Crittenden DB, Adachi JD, Binkley N, Czerwinski E et al. 2016. Romosozumab treatment in postmenopausal women with osteoporosis. N. Engl. J. Med. 375:1532–43
    [Google Scholar]
25. Cruciat CM, Ohkawara B, Acebron SP, Karaulanov E, Reinhard C et al. 2010. Requirement of prorenin receptor and vacuolar H⁺-ATPase-mediated acidification for Wnt signaling. Science 327:459–63
    [Google Scholar]
26. Cselenyi CS, Jernigan KK, Tahinci E, Thorne CA, Lee LA, Lee E 2008. LRP6 transduces a canonical Wnt signal independently of Axin degradation by inhibiting GSK3’s phosphorylation of β-catenin. PNAS 105:8032–37
    [Google Scholar]
27. Davidson G, Wu W, Shen J, Bilić J, Fenger U et al. 2005. Casein kinase 1γ couples Wnt receptor activation to cytoplasmic signal transduction. Nature 438:867–72
    [Google Scholar]
28. De Duve C, Wattiaux R. 1966. Functions of lysosomes. Annu. Rev. Physiol. 28:435–92
    [Google Scholar]
29. de Lau W, Barker N, Low TY, Koo B-K, Li VS et al. 2011. Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling. Nature 476:293–97
    [Google Scholar]
30. De Robertis EM, Kuroda H. 2004. Dorsal-ventral patterning and neural induction in Xenopus embryos. Annu. Rev. Cell Dev. Biol. 20:285–308
    [Google Scholar]
31. Dharmawardhane S, Schurmann A, Sells MA, Chernoff J, Schmid SL, Bokoch GM. 2000. Regulation of macropinocytosis by p21-activated kinase-1. Mol. Biol. Cell 11:3341–52
    [Google Scholar]
32. Ding Y, Colozza G, Sosa EA, Moriyama Y, Rundle S et al. 2018. Bighead is a Wnt antagonist secreted by the Xenopus Spemann organizer that promotes Lrp6 endocytosis. PNAS 115:E9135–44
    [Google Scholar]
33. Dobrowolski R, De Robertis EM. 2011. Endocytic control of growth factor signalling: multivesicular bodies as signalling organelles. Nat. Rev. Mol. Cell Biol. 13:53–60
    [Google Scholar]
34. Dobrowolski R, Vick P, Ploper D, Gumper I, Snitkin H et al. 2012. Presenilin deficiency or lysosomal inhibition enhances Wnt signaling through relocalization of GSK3 to the late-endosomal compartment. Cell Rep 2:1316–28
    [Google Scholar]
35. Doherty GJ, McMahon HT. 2009. Mechanisms of endocytosis. Annu. Rev. Biochem. 78:857–902
    [Google Scholar]
36. Dow LE, O'Rourke KP, Simon J, Tschaharganeh DF, van Es JH et al. 2015. Apc restoration promotes cellular differentiation and reestablishes crypt homeostasis in colorectal cancer. Cell 161:1539–52
    [Google Scholar]
37. Dubey R, van Kerkhof P, Jordens I, Malinauskas T, Pusapati GV et al. 2020. R-spondins engage heparan sulfate proteoglycans to potentiate WNT signaling. eLife 9:e54469
    [Google Scholar]
38. Faux MC, Ross JL, Meeker C, Johns T, Ji H et al. 2004. Restoration of full-length adenomatous polyposis coli (APC) protein in a colon cancer cell line enhances cell adhesion. J. Cell Sci. 117:427–39
    [Google Scholar]
39. Galluzzi L, Spranger S, Fuchs E, Lopez-Soto A. 2019. WNT signaling in cancer immunosurveillance. Trends Cell Biol 29:44–65
    [Google Scholar]
40. Gammons M, Bienz M. 2018. Multiprotein complexes governing Wnt signal transduction. Curr. Opin. Cell Biol. 51:42–49
    [Google Scholar]
41. Giebel N, de Jaime-Soguero A, García del Arco A, Landry JJM, Tietje M et al. 2021. USP42 protects ZNRF3/RNF43 from R-spondin-dependent clearance and inhibits Wnt signaling. EMBO Rep 30:e51415
    [Google Scholar]
42. Glinka A, Dolde C, Kirsch N, Huang Y-L, Kazanskaya O et al. 2011. LGR4 and LGR5 are R-spondin receptors mediating Wnt/β-catenin and Wnt/PCP signalling. EMBO Rep 12:1055–61
    [Google Scholar]
43. Glinka A, Wu W, Delius H, Monaghan AP, Blumenstock C, Niehrs C. 1998. Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction. Nature 391:357–62
    [Google Scholar]
44. Grainger S, Nguyen N, Richter J, Setayesh J, Lonquich B et al. 2019. EGFR is required for Wnt9a–Fzd9b signalling specificity in haematopoietic stem cells. Nat. Cell Biol. 21:721–30
    [Google Scholar]
45. Haigler HT, McKanna JA, Cohen S. 1979. Rapid stimulation of pinocytosis in human carcinoma cells A-431 by epidermal growth factor. J. Cell Biol. 83:82–90
    [Google Scholar]
46. Han T, Schatoff EM, Murphy C, Zafra MP, Wilkinson JE et al. 2017. R-spondin chromosome rearrangements drive Wnt-dependent tumour initiation and maintenance in the intestine. Nat. Commun. 8:15945
    [Google Scholar]
47. Hao HX, Xie Y, Zhang Y, Charlat O, Oster E et al. 2012. ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner. Nature 485:195–200
    [Google Scholar]
48. Herr P, Basler K. 2012. Porcupine-mediated lipidation is required for Wnt recognition by Wls. Dev. Biol. 361:392–402
    [Google Scholar]
49. Hershko A, Ciechanover A. 1998. The ubiquitin system. Annu. Rev. Biochem. 67:425–79
    [Google Scholar]
50. Hinze L, Labrosse R, Degar J, Han T, Schatoff EM et al. 2020. Exploiting the therapeutic interaction of WNT pathway activation and asparaginase for colorectal cancer therapy. Cancer Discov 10:1690–705
    [Google Scholar]
51. Hodakoski C, Hopkins BD, Zhang G, Su T, Cheng Z et al. 2019. Rac-mediated macropinocytosis of extracellular protein promotes glucose independence in non-small cell lung cancer. Cancers 11:37
    [Google Scholar]
52. Hsieh JC, Kodjabachian L, Rebbert ML, Rattner A, Smallwood PM et al. 1999. A new secreted protein that binds to Wnt proteins and inhibits their activities. Nature 398:431–36
    [Google Scholar]
53. Huang SM, Mishina YM, Liu S, Cheung A, Stegmeier F et al. 2009. Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. Nature 461:614–20
    [Google Scholar]
54. Janda CY, Waghray D, Levin AM, Thomas C, Garcia KC. 2012. Structural basis of Wnt recognition by Frizzled. Science 337:59–64
    [Google Scholar]
55. Jeong W-J, Yoon J, Park J-C, Lee S-H, Kaduwal S et al. 2012. Ras stabilization through aberrant activation of Wnt/β-catenin signaling promotes intestinal tumorigenesis. Sci. Signal. 5:ra30
    [Google Scholar]
56. Jho E-H, Zhang T, Domon C, Joo C-K, Freund J-N, Costantini F. 2002. Wnt/β-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol. Cell. Biol. 22:1172–83
    [Google Scholar]
57. Joiner DM, Ke J, Zhong Z, Xu HE, Williams BO. 2013. LRP5 and LRP6 in development and disease. Trends Endocrinol. Metab. 24:31–39
    [Google Scholar]
58. Jung Y-S, Jun S, Kim MJ, Lee SH, Suh HN et al. 2018. TMEM9 promotes intestinal tumorigenesis through vacuolar-ATPase-activated Wnt/β-catenin signalling. Nat. Cell Biol. 20:1421–33
    [Google Scholar]
59. Kanarek N, Petrova B, Sabatini DM. 2020. Dietary modifications for enhanced cancer therapy. Nature 579:507–17
    [Google Scholar]
60. Kazanskaya O, Glinka A, del Barco Barrantes I, Stannek P, Niehrs C, Wu W 2004. R-spondin2 is a secreted activator of Wnt/β-catenin signaling and is required for Xenopus myogenesis. Dev. Cell 7:525–34
    [Google Scholar]
61. Kim H, Vick P, Hedtke J, Ploper D, De Robertis EM. 2015. Wnt signaling translocates Lys48-linked polyubiquitinated proteins to the lysosomal pathway. Cell Rep 11:1151–59
    [Google Scholar]
62. Kim K-A, Kakitani M, Zhao J, Oshima T, Tang T et al. 2005. Mitogenic influence of human R-spondin1 on the intestinal epithelium. Science 309:1256–59
    [Google Scholar]
63. Kim S-E, Huang H, Zhao M, Zhang X, Zhang A et al. 2013. Wnt stabilization of β-catenin reveals principles for morphogen receptor-scaffold assemblies. Science 340:867–70
    [Google Scholar]
64. Kirsch N, Chang LS, Koch S, Glinka A, Dolde C et al. 2017. Angiopoietin-like 4 is a Wnt signaling antagonist that promotes LRP6 turnover. Dev. Cell 43:71–82.e6
    [Google Scholar]
65. Kleeman SO, Koelzer VH, Jones HJ, Vazquez EG, Davis H et al. 2020. Exploiting differential Wnt target gene expression to generate a molecular biomarker for colorectal cancer stratification. Gut 69:1092–103
    [Google Scholar]
66. Koch S, Acebron SP, Herbst J, Hatiboglu G, Niehrs C. 2015. Post-transcriptional Wnt signaling governs epididymal sperm maturation. Cell 163:1225–36
    [Google Scholar]
67. Koivusalo M, Welch C, Hayashi H, Scott CC, Kim M et al. 2010. Amiloride inhibits macropinocytosis by lowering submembranous pH and preventing Rac1 and Cdc42 signaling. J. Cell Biol. 188:547–63
    [Google Scholar]
68. Koo B-K, Spit M, Jordens I, Low TY, Stange DE et al. 2012. Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors. Nature 488:665–69
    [Google Scholar]
69. Langdahl BL, Libanati C, Crittenden DB, Bolognese MA, Brown JP et al. 2017. Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial. Lancet 390:1585–94
    [Google Scholar]
70. Lebensohn AM, Rohatgi R 2018. R-spondins can potentiate WNT signaling without LGRs. eLife 7:e33126
    [Google Scholar]
71. Lee H-J, Jedrychowski MP, Vinayagam A, Wu N, Shyh-Chang N et al. 2017. Proteomic and metabolomic characterization of a mammalian cellular transition from quiescence to proliferation. Cell Rep 20:721–36
    [Google Scholar]
72. Lewis WH. 1931. Pinocytosis. Bull. Johns Hopkins Hosp. 49:17–27
    [Google Scholar]
73. Leyns L, Bouwmeester T, Kim SH, Piccolo S, De Robertis EM. 1997. Frzb-1 is a secreted antagonist of Wnt signaling expressed in the Spemann organizer. Cell 88:747–56
    [Google Scholar]
74. Li X, Wang C, Jiang H, Luo C. 2019. A patent review of arginine methyltransferase inhibitors (2010–2018). Expert Opin. Ther. Pat. 29:97–114
    [Google Scholar]
75. Lin Y-C, Haas A, Bufe A, Parbin S, Hennecke M et al. 2021. Wnt10b-GSK3β-dependent Wnt/STOP signaling prevents aneuploidy in human somatic cells. Life Sci. Alliance 4:e202000855
    [Google Scholar]
76. Liu H, Fergusson MM, Castilho RM, Liu J, Cao L et al. 2007. Augmented Wnt signaling in a mammalian model of accelerated aging. Science 317:803–6
    [Google Scholar]
77. Logan CY, Nusse R. 2004. The Wnt signaling pathway in development and disease. Annu. Rev. Cell Dev. Biol. 20:781–810
    [Google Scholar]
78. Loh KM, van Amerongen R, Nusse R. 2016. Generating cellular diversity and spatial form: Wnt signaling and the evolution of multicellular animals. Dev. Cell 38:643–55
    [Google Scholar]
79. MacDonald BT, Tamai K, He X. 2009. Wnt/β-catenin signaling: components, mechanisms, and diseases. Dev. Cell 17:9–26
    [Google Scholar]
80. Malinauskas T, Aricescu AR, Lu W, Siebold C, Jones EY. 2011. Modular mechanism of Wnt signaling inhibition by Wnt inhibitory factor 1. Nat. Struct. Mol. Biol. 18:886–93
    [Google Scholar]
81. Mao B, Wu W, Davidson G, Marhold J, Li M et al. 2002. Kremen proteins are Dickkopf receptors that regulate Wnt/β-catenin signalling. Nature 417:664–67
    [Google Scholar]
82. McClung MR, Grauer A. 2014. Romosozumab in postmenopausal women with osteopenia. N. Engl. J. Med. 370:1664–65
    [Google Scholar]
83. Mii Y, Taira M. 2009. Secreted Frizzled-related proteins enhance the diffusion of Wnt ligands and expand their signalling range. Development 136:4083–88
    [Google Scholar]
84. Nichols BJ, Lippincott-Schwartz J. 2001. Endocytosis without clathrin coats. Trends Cell Biol 11:406–12
    [Google Scholar]
85. Niehrs C. 2012. The complex world of WNT receptor signalling. Nat. Rev. Mol. Cell Biol. 13:767–79
    [Google Scholar]
86. Niehrs C, Shen J. 2010. Regulation of Lrp6 phosphorylation. Cell Mol. Life Sci. 67:2551–62
    [Google Scholar]
87. Nusse R, Clevers H. 2017. Wnt/β-catenin signaling, disease, and emerging therapeutic modalities. Cell 169:985–99
    [Google Scholar]
88. O'Rourke KP, Loizou E, Livshits G, Schatoff EM, Baslan T et al. 2017. Transplantation of engineered organoids enables rapid generation of metastatic mouse models of colorectal cancer. Nat. Biotechnol. 35:577–82
    [Google Scholar]
89. Palm W, Park Y, Wright K, Pavlova NN, Tuveson DA, Thompson CB. 2015. The utilization of extracellular proteins as nutrients is suppressed by mTORC1. Cell 162:259–70
    [Google Scholar]
90. Palm W, Thompson CB. 2017. Nutrient acquisition strategies of mammalian cells. Nature 546:234–42
    [Google Scholar]
91. Park S, Cui J, Yu W, Wu L, Carmon KS, Liu QJ. 2018. Differential activities and mechanisms of the four R-spondins in potentiating Wnt/beta-catenin signaling. J. Biol. Chem. 293:9759–69
    [Google Scholar]
92. Pate KT, Stringari C, Sprowl-Tanio S, Wang K, TeSlaa T et al. 2014. Wnt signaling directs a metabolic program of glycolysis and angiogenesis in colon cancer. EMBO J 33:1454–73
    [Google Scholar]
93. Patel P, Woodgett JR. 2017. Glycogen synthase kinase 3: a kinase for all pathways?. Curr. Top. Dev. Biol 123:277–302
    [Google Scholar]
94. Pavlova NN, Thompson CB. 2016. The emerging hallmarks of cancer metabolism. Cell Metab 23:27–47
    [Google Scholar]
95. Perera RM, Di Malta C, Ballabio A. 2019. MiT/TFE family of transcription factors, lysosomes, and cancer. Annu. Rev. Cancer Biol. 3:203–22
    [Google Scholar]
96. Piccolo S, Agius E, Leyns L, Bhattacharyya S, Grunz H et al. 1999. The head inducer Cerberus is a multifunctional antagonist of Nodal. BMP and Wnt signals. Nature 397:707–10
    [Google Scholar]
97. Recouvreux MV, Commisso C. 2017. Macropinocytosis: a metabolic adaptation to nutrient stress in cancer. Front. Endocrinol. 8:261
    [Google Scholar]
98. Redelman-Sidi G, Binyamin A, Gaeta I, Palm W, Thompson CB et al. 2018. The canonical Wnt pathway drives macropinocytosis in cancer. Cancer Res 78:4658–70
    [Google Scholar]
99. Riffell JL, Lord CJ, Ashworth A. 2012. Tankyrase-targeted therapeutics: expanding opportunities in the PARP family. Nat. Rev. Drug Discov. 11:923–36
    [Google Scholar]
100. Rim EY, Kinney LK, Nusse R. 2020. β-Catenin-mediated Wnt signal transduction proceeds through an endocytosis-independent mechanism. Mol. Biol. Cell 31:1425–36
     [Google Scholar]
101. Rodgers SJ, Ooms LM, Oorschot VMJ, Schittenhelm RB, Nguyen EV et al. 2021. INPP4B promotes PI3Kα-dependent late endosome formation and Wnt/β-catenin signaling in breast cancer. Nat. Commun 12:3140
     [Google Scholar]
102. Saag KG, Petersen J, Brandi ML, Karaplis AC, Lorentzon M et al. 2017. Romosozumab or Alendronate for fracture prevention in women with osteoporosis. N. Engl. J. Med. 377:1417–27
     [Google Scholar]
103. Saito-Diaz K, Benchabane H, Tiwari A, Tian A, Li B et al. 2018. APC inhibits ligand-independent Wnt signaling by the clathrin endocytic pathway. Dev. Cell 44:566–81.e8
     [Google Scholar]
104. Schatoff EM, Goswami S, Zafra MP, Foronda M, Shusterman M et al. 2019. Distinct colorectal cancer-associated APC mutations dictate response to Tankyrase inhibition. Cancer Discov 9:1358–71
     [Google Scholar]
105. Seshagiri S, Stawiski EW, Durinck S, Modrusan Z, Storm EE et al. 2012. Recurrent R-spondin fusions in colon cancer. Nature 488:660–64
     [Google Scholar]
106. Stamos JL, Weis WI. 2013. The β-catenin destruction complex. Cold Spring Harb. Perspect. Biol. 5:a007898
     [Google Scholar]
107. Swanson JA, King JS. 2019. The breadth of macropinocytosis research. Philos. Trans. R. Soc. B 374:20180146
     [Google Scholar]
108. Szenker-Ravi E, Altunoglu U, Leushacke M, Bosso-Lefevre C, Khatoo M et al. 2018. RSPO2 inhibition of RNF43 and ZNRF3 governs limb development independently of LGR4/5/6. Nature 557:564–69
     [Google Scholar]
109. Taelman VF, Dobrowolski R, Plouhinec JL, Fuentealba LC, Vorwald PP et al. 2010. Wnt signaling requires sequestration of glycogen synthase kinase 3 inside multivesicular endosomes. Cell 143:1136–48
     [Google Scholar]
110. Tejeda-Muñoz N, Albrecht LV, Bui MH, De Robertis EM 2019. Wnt canonical pathway activates macropinocytosis and lysosomal degradation of extracellular proteins. PNAS 116:10402–11
     [Google Scholar]
111. Uren A, Reichsman F, Anest V, Taylor WG, Muraiso K et al. 2000. Secreted Frizzled-related protein-1 binds directly to Wingless and is a biphasic modulator of Wnt signaling. J. Biol. Chem. 275:4374–82
     [Google Scholar]
112. Vinyoles M, Del Valle-Pérez B, Curto J, Viñas-Castells R, Alba-Castellón L et al. 2014. Multivesicular GSK3 sequestration upon Wnt signaling is controlled by p120-catenin/cadherin interaction with LRP5/6. Mol. Cell 53:444–57
     [Google Scholar]
113. West MA, Bretscher MS, Watts C. 1989. Distinct endocytotic pathways in epidermal growth factor-stimulated human carcinoma A431 cells. J. Cell Biol. 109:2731–39
     [Google Scholar]
114. Xu Q, Wang Y, Dabdoub A, Smallwood PM, Williams J et al. 2004. Vascular development in the retina and inner ear: control by Norrin and Frizzled-4, a high-affinity ligand-receptor pair. Cell 116:883–95
     [Google Scholar]
115. Xu YK, Nusse R. 1998. The Frizzled CRD domain is conserved in diverse proteins including several receptor tyrosine kinases. Curr. Biol. 8:R405–6
     [Google Scholar]
116. Yamamoto H, Komekado H, Kikuchi A. 2006. Caveolin is necessary for Wnt-3a-dependent internalization of LRP6 and accumulation of β-catenin. Dev. Cell 11:213–23
     [Google Scholar]
117. Yoshida S, Pacitto R, Inoki K, Swanson J. 2018. Macropinocytosis, mTORC1 and cellular growth control. Cell Mol. Life Sci. 75:1227–39
     [Google Scholar]
118. Zebisch M, Xu Y, Krastev C, MacDonald BT, Chen M et al. 2013. Structural and molecular basis of ZNRF3/RNF43 transmembrane ubiquitin ligase inhibition by the Wnt agonist R-spondin. Nat. Commun. 4:2787
     [Google Scholar]
119. Zehir A, Benayed R, Shah RH, Syed A, Middha S et al. 2017. Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nat. Med. 23:703–13
     [Google Scholar]
120. Zhang X, Cheong S-M, Amado NG, Reis AH, MacDonald BT et al. 2015. Notum is required for neural and head induction via Wnt deacylation, oxidation, and inactivation. Dev. Cell 32:719–30
     [Google Scholar]
121. Zhang Y, Commisso C. 2019. Macropinocytosis in cancer: a complex signaling network. Trends Cancer 5:332–34
     [Google Scholar]
122. Zimmerli D, Hausmann G, Cantu C, Basler K. 2017. Pharmacological interventions in the Wnt pathway: inhibition of Wnt secretion versus disrupting the protein-protein interfaces of nuclear factors. Br. J. Pharmacol. 174:4600–10
     [Google Scholar]